European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-24

Active controlled transdermal drug delivery systems

Objetivo

The proposal aims to develop functional materials and systems to fulfill the need for safe, actively controlled transdermal drug delivery. The effective combination of the partner's skills and resources will develop drug delivery systems to meet several patient centred objectives: e.g.wider use of self administered drugs , at home with a wearable system, more accurate matching of drug dose to drug need, avoiding side effects and long-term complications in chronic diseases (e.g. diabetes and osteoporosis) and improve patient compliance by replacing self injection. This project seeks to extend the scale and range of drugs currently administered non-invasively-e.g. beyond small scale anesthetics and pain killers. The economic impact is to reduce hospitalization, reduce use of PVC consumables and develop a new sector of European health industry .

Palabras clave

Convocatoria de propuestas

Data not available

Régimen de financiación

CSC - Cost-sharing contracts

Coordinador

BAXTER RESEARCH AND DEVELOPMENT EUROPE
Aportación de la UE
Sin datos
Dirección
Rue du Progres 7
1400 NIVELLES
Bélgica

Ver en el mapa

Coste total
Sin datos

Participantes (5)